Servier rebuts Mediator "epidemic of lawsuits"
This article was originally published in Scrip
Executive Summary
As Servier begins French court proceedings over the controversial drug, Mediator (benfluorex), it has been retaliating against media amplification of claims made against the company by victims' lawyers and the government investigator, IGAS (Inspection générale des affaires sociales).